Tag: Parliamentary Question

  • Louise Ellman – 2015 Parliamentary Question to the Attorney General

    Louise Ellman – 2015 Parliamentary Question to the Attorney General

    The below Parliamentary question was asked by Louise Ellman on 2015-11-18.

    To ask the Attorney General, whether he plans to change the arrangements or level of funding for specialist rape and sexual offence prosecutors; and if he will make a statement.

    Robert Buckland

    Any consideration of future funding proposals would form part of the Spending Review which will be announced in due course.

    However, the CPS has been refocusing its existing resources to support Rape and Serious Sexual Offence (RASSO) units, including through a recruitment exercise to increase the size of the units and an extensive training programme to further support staff within them. The CPS is also working closely with the police through a high-level RASSO Steering Group to further ensure the consistent application of policies, including in relation to the seeking and provision of early investigative advice.

  • Lord Teverson – 2015 Parliamentary Question to the HM Treasury

    Lord Teverson – 2015 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Teverson on 2015-12-10.

    To ask Her Majesty’s Government why they afforded community energy schemes less than one month’s notice for the implementation of changes to the tax rules, but allowed a phasing out of Enterprise Investment Scheme relief for all generation projects over a longer period.

    Lord O’Neill of Gatley

    The purpose of the tax-advantaged venture capital schemes is to encourage investment into smaller, higher risk companies that would otherwise struggle to access the funding they need to develop and grow.

    Changes have been made to the schemes over time to ensure that asset-backed activities, as well as those that benefit from predictable and reliable income streams, do not qualify, since these often represent lower-risk investments that should be able to secure finance without the need for tax relief. For example, different types of energy generation were excluded from the schemes in 2012, 2014 and 2015, due to clear evidence that such investments were particularly low-risk products offering return of capital, and were being explicitly marketed as such.

    Community energy projects in receipt of other government support were not excluded at the time of these previous changes. However, since then the government has become aware of significantly increased interest in the use of community energy for low-risk tax planning purposes. The number of community energy schemes registered as community interest companies (CICs) or community benefit societies has increased from about 5 in 2014 to about 200 by October 2015. The marketing material of these investments suggests that the level of investment risk for community energy, including solar, is comparable to that of activities that were previously excluded.

    The government announced at the Summer Budget 2015 that it would monitor the use of the venture capital schemes by community energy organisations to ensure that there was continued value for money for the taxpayer and that they were not the subject of misuse. The government subsequently announced the exclusion of subsidised renewable energy generation by community energy organisations on 26 October 2015, taking effect for investments made on or after 30 November 2015, providing a notice period of five weeks. At the same time, the government announced the exclusion of activities making reserve energy generating capacity available, also with effect for investments made on or after 30 November 2015.

    The government believes that the notice period given provided a good balance between the provision of notice to potential investors who might wish to take advantage of the tax reliefs provided through the schemes and the financial risk to the Exchequer that a longer notice period would carry.

    To further ensure the venture capital schemes remain well-targeted and deliver value for money, the government announced at Autumn Statement 2015 the exclusion of all remaining energy generation activities from the schemes with effect for investments made on or after 6 April 2016. The new exclusions will apply to both non-renewable and renewable sources of energy generation and apply irrespective of whether a subsidy is received or of the nature of the company carrying on the activities.

  • Rosie Cooper – 2016 Parliamentary Question to the Department for Transport

    Rosie Cooper – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Rosie Cooper on 2016-01-21.

    To ask the Secretary of State for Transport, what the proposed timescales are for the completion of the business case work for the electrification of the Southport to Salford Crescent and Kirkby to Salford Crescent railway lines set out in the March 2015 report of the North of England Electrification Task Force.

    Andrew Jones

    The report of the independent North of England Electrification Task Force made recommendations on the prioritisation for a rolling programme of electrification of all currently unelectrified lines in the North, in three tiers. It recommended that full business case analysis of all Tier 1 schemes should be urgently progressed. Both Southport-Salford Crescent and Kirby-Salford Crescent were placed in Tier 1.

    The Task Force’s recommendations are being taken into account by Network Rail as it prepares an updated national electrification strategy based on a comprehensive sifting and appraisal process. The strategy will be subject to public consultation this year and will inform the Government’s Rail Investment Strategy for 2019-2024.

  • Valerie Vaz – 2016 Parliamentary Question to the Department of Health

    Valerie Vaz – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Valerie Vaz on 2016-02-19.

    To ask the Secretary of State for Health, if he will ensure continued Government funding for the Neurology Intelligence Network through NHS England and Public Health England.

    Jane Ellison

    Sir Bruce Keogh, NHS England’s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future.

    Where there will no longer be a specific NCD role, NHS England will secure expert clinical advice from its clinical networks, through its relationships with professional bodies and by appointing clinical advisors. For neurology, it is planned that advice will be provided through a range of sources such as: clinical leads and members of the NHS England-funded neurology clinical networks; the Neurology Clinical Reference Group; and the Royal Colleges. It is expected that these new arrangements will be in place from 1 April 2016.

    The Neurology Intelligence Network (NIN) is a joint partnership programme between Public Health England (PHE) and NHS England to support the generation and dissemination of neurology-related health intelligence. The NIN, which is currently funded by PHE, faces no change to its current resource for the next financial year.

  • Paula Sherriff – 2016 Parliamentary Question to the Department of Health

    Paula Sherriff – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Paula Sherriff on 2016-03-14.

    To ask the Secretary of State for Health, what international comparisons his Department is drawing on to inform implementation of a gender-neutral HPV vaccination programme.

    Jane Ellison

    The Joint Committee on Vaccination and Immunisation (JCVI), the expert committee that advises Ministers on immunisation related issues, is currently considering whether a human papillomavirus vaccination programme for boys, in addition to that in place for girls, would be cost-effective.

    The JCVI considers evidence from a range of sources including published data and experiences in other countries.

    It is important to note that other epidemiological circumstances and situations in other countries may differ and may therefore not transfer to the United Kingdom. The advice of the JCVI is made with reference to the UK immunisation programme.

  • Andrew Stephenson – 2016 Parliamentary Question to the Department of Health

    Andrew Stephenson – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Stephenson on 2016-04-13.

    To ask the Secretary of State for Health, how much the NHS spent on Lyme disease laboratory tests in each of the last three years.

    Jane Ellison

    As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.

    The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.

    Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.

    There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.

  • Jonathan Ashworth – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Jonathan Ashworth – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Jonathan Ashworth on 2016-05-20.

    To ask the Secretary of State for Business, Innovation and Skills, with reference to the press release, PM holds major summit as part of global drive to expose, punish and drive out corruption, published on 12 May 2016, whether he plans to bring forward legislative proposals requiring foreign companies that own property in the UK to declare their real owners.

    Anna Soubry

    At the International Anti-Corruption Summit in London on 12 May, my Rt hon Friend the Prime Minister announced that we will require foreign companies that own or purchase UK properties or bid on UK Government procurement contracts to provide details of their beneficial owners to a public central register. This will be the first register of its kind in the world.

    The Department for Business, Innovation and Skills will consult with experts to develop the policy throughout the year and consult formally on the detail of the policy in due course. Implementation of the new register requirements is expected to require both primary and secondary legislation, which we intend to introduce when Parliamentary time allows.

  • Nicholas Brown – 2016 Parliamentary Question to the Department of Health

    Nicholas Brown – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Brown on 2016-07-06.

    To ask the Secretary of State for Health, what guidance his Department provides for people on their options for accessing safe and reliable treatments which are not offered through the NHS.

    George Freeman

    The decision to be treated privately outside the National Health Service is one for individuals and their clinicians to make, in accordance with the relevant professional and regulatory requirements.

    Guidance on NHS patients who wish to pay for additional private care was issued in 2009 and is available at:

    www.gov.uk/government/uploads/system/uploads/attachment_data/file/404423/patients-add-priv-care.pdf

    “

  • Louise Haigh – 2016 Parliamentary Question to the HM Treasury

    Louise Haigh – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Louise Haigh on 2016-09-15.

    To ask Mr Chancellor of the Exchequer, what representations he has received from Concentrix on the non-renewal of its contract with HM Revenue and Customs.

    Jane Ellison

    HM Revenue and Customs, in line with procurement and contract management best practice and protocol, have appropriate dialogue with all its suppliers in relation to potential contract extension. Such discussions are of course commercially sensitive and cannot, in this instance, be disclosed.

  • Nic Dakin – 2015 Parliamentary Question to the Northern Ireland Office

    Nic Dakin – 2015 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by Nic Dakin on 2015-11-18.

    To ask the Secretary of State for Northern Ireland, what steps her Department has taken to embed the family test into its policy making.

    Mr Ben Wallace

    Officials in my Department have liaised with DWP as the lead Department for the Family Test to embed it into the policy process. This has included training officials on applying the Test, disseminating relevant evidence, learning materials and best practice.